Longevity & Anti-Aging Science
Track the latest breakthroughs in aging research, clinical trials, and longevity science. From age reversal trials and peptide therapies (BPC-157, rapamycin) to stem cell research and NMN studies — curated weekly for people serious about living longer and healthier.
Subscribe to receive new issues
Recent Issues
More from Oria
Is AI replacing humans on job markets?
With surging AI investments and automation capabilities, is the job market facing mass displacement or new opportunities? We analyze AI's dual impact on headcount, exploring the paradox of job destruction versus creation.
Agentic software development
AI is rapidly transforming the software development lifecycle. This newsletter tracks emerging agentic tools and frameworks, providing enterprise-focused coverage on code generation, governance, deployment, and security from leading tech players and startups.
AppSec Briefing
A briefing on application security developments — supply chain attacks, AI code risks, DevSecOps tooling, and how engineering teams are securing their software pipelines.
SRE Briefing
A briefing on site reliability engineering — production incidents, observability developments, AIOps, SLO practices, and how teams are keeping systems reliable.
CI/CD & Release Engineering Briefing
A briefing on CI/CD and release engineering — pipeline tooling, deployment strategies, build optimization, and developer productivity metrics for engineers who own the path from commit to production.
Platform and Infra Briefing
A briefing on platform and infrastructure engineering — Kubernetes, cloud infrastructure, networking, infrastructure as code, and the cloud native ecosystem.
Biohacking Therapies & Devices
Your weekly guide to the tools, therapies, and devices biohackers actually use. Covering red light therapy, cold plunge and sauna science, wearables (Oura, WHOOP, Ultrahuman), and the latest health tracking technology — backed by research, not hype.
Psychedelic Therapy
Follow the rapidly evolving world of psychedelic medicine. From FDA approval pathways and clinical trials to state legalization and cutting-edge brain research — a weekly digest for anyone tracking the psychedelic therapy revolution.